{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:14:34Z","timestamp":1767705274680},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,1,12]],"date-time":"2004-01-12T00:00:00Z","timestamp":1073865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,1,12]],"date-time":"2004-01-12T00:00:00Z","timestamp":1073865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,3,1]]},"DOI":"10.1038\/sj.bmt.1704381","type":"journal-article","created":{"date-parts":[[2004,1,12]],"date-time":"2004-01-12T08:44:12Z","timestamp":1073897052000},"page":"531-534","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome"],"prefix":"10.1038","volume":"33","author":[{"given":"S","family":"Depil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Deconinck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Witz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P","family":"Jouet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On behalf of the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et Th\u00e9rapie cellulaire (SFGM-TC)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,1,12]]},"reference":[{"key":"BF1704381_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1200\/JCO.1986.4.4.589","volume":"4","author":"VJ Picozzi Jr","year":"1986","unstructured":"Picozzi Jr VJ, Swanson GF, Morgan R et al. 13-cis retinoic acid treatment for myelodysplastic syndromes. J Clin Oncol 1986; 4: 589\u2013595.","journal-title":"J Clin Oncol"},{"key":"BF1704381_CR2","first-page":"1399","volume":"69","author":"HP Koeffler","year":"1985","unstructured":"Koeffler HP, Hirji K, Itri L . 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep 1985; 69: 1399\u20131407.","journal-title":"Cancer Treat Rep"},{"key":"BF1704381_CR3","first-page":"105","volume":"1","author":"L Elias","year":"1987","unstructured":"Elias L, Hoffman R, Boswell S et al. A trial of recombinant alpha 2 interferon in the myelodysplastic syndromes: I. Clinical results. Leukemia 1987; 1: 105\u2013110.","journal-title":"Leukemia"},{"key":"BF1704381_CR4","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1182\/blood.V80.10.2463.2463","volume":"80","author":"WJ Gradishar","year":"1992","unstructured":"Gradishar WJ, Le Beau MM, O'Laughlin R et al. Clinical and cytogenetic responses to granulocyte\u2013macrophage colony-stimulating factor in therapy-related myelodysplasia. Blood 1992; 80: 2463\u20132470.","journal-title":"Blood"},{"key":"BF1704381_CR5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V82.2.677.677","volume":"82","author":"JE Anderson","year":"1993","unstructured":"Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993; 82: 677\u2013681.","journal-title":"Blood"},{"key":"BF1704381_CR6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V88.1.358.358","volume":"88","author":"L Sutton","year":"1996","unstructured":"Sutton L, Chastang C, Ribaud P et al. Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients. Societe Francaise de Greffe de Moelle. Blood 1996; 88: 358\u2013365.","journal-title":"Blood"},{"key":"BF1704381_CR7","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/sj.bmt.1701269","volume":"21","author":"R Arnold","year":"1998","unstructured":"Arnold R, de Witte T, van Biezen A et al. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group. Bone Marrow Transplant 1998; 21: 1213\u20131216.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704381_CR8","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1200\/JCO.2000.18.5.963","volume":"18","author":"I Yakoub-Agha","year":"2000","unstructured":"Yakoub-Agha I, de La Salmoniere P, Ribaud P et al. Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients \u2013 report of the French society of bone marrow transplantation. J Clin Oncol 2000; 18: 963\u2013971.","journal-title":"J Clin Oncol"},{"key":"BF1704381_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2141.1992.tb06397.x","volume":"80","author":"JO Cullis","year":"1992","unstructured":"Cullis JO, Schwarer AP, Hughes TP et al. Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T-depleted donor marrow: feasibility of using busulphan alone for re-conditioning. Br J Haematol 1992; 80: 33\u201339.","journal-title":"Br J Haematol"},{"key":"BF1704381_CR10","first-page":"39","volume":"17","author":"KY Chiang","year":"1996","unstructured":"Chiang KY, Weisdorf DJ, Davies SM et al. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse. Bone Marrow Transplant 1996; 17: 39\u201342.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704381_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/sj.bmt.1700680","volume":"19","author":"K Kishi","year":"1997","unstructured":"Kishi K, Takahashi S, Gondo H et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant 1997; 19: 461\u2013466.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704381_CR12","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195","volume":"87","author":"S Slavin","year":"1996","unstructured":"Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195\u20132204.","journal-title":"Blood"},{"key":"BF1704381_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood.V94.2.434","volume":"94","author":"WR Drobyski","year":"1999","unstructured":"Drobyski WR, Hessner MJ, Klein JP et al. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. Blood 1999; 94: 434\u2013441.","journal-title":"Blood"},{"key":"BF1704381_CR14","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood.V95.8.2645","volume":"95","author":"DL Porter","year":"2000","unstructured":"Porter DL, Collins Jr RH, Hardy C et al. Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions. Blood 2000; 95: 1214\u20131221.","journal-title":"Blood"},{"key":"BF1704381_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1182\/blood.V100.2.397","volume":"100","author":"C Guglielmi","year":"2002","unstructured":"Guglielmi C, Arcese W, Dazzi F et al. Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose. Blood 2002; 100: 397\u2013405.","journal-title":"Blood"},{"key":"BF1704381_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins Jr","year":"1997","unstructured":"Collins Jr RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433\u2013444.","journal-title":"J Clin Oncol"},{"key":"BF1704381_CR17","first-page":"975","volume":"18","author":"DL Porter","year":"1996","unstructured":"Porter DL, Roth MS, Lee SJ . Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 18: 975\u2013980.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704381_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/10428199809068567","volume":"29","author":"C Helg","year":"1998","unstructured":"Helg C, Starobinski M, Jeannet M, Chapuis B . Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 1998; 29: 301\u2013313.","journal-title":"Leuk Lymphoma"},{"key":"BF1704381_CR19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/sj.bmt.1702596","volume":"26","author":"S Shiobara","year":"2000","unstructured":"Shiobara S, Nakao S, Ueda M et al. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome. Bone Marrow Transplant 2000; 26: 769\u2013774.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704381_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189\u2013199.","journal-title":"Br J Haematol"},{"key":"BF1704381_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BF1704381_CR22","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1097\/00007890-200004150-00025","volume":"69","author":"N Novitzky","year":"2000","unstructured":"Novitzky N, Rubinstein R, Hallett JM et al. Bone marrow transplantation depleted of T cells followed by repletion with incremental doses of donor lymphocytes for relapsing patients with chronic myeloid leukemia: a therapeutic strategy. Transplantation 2000; 69: 1358\u20131363.","journal-title":"Transplantation"},{"key":"BF1704381_CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood.V95.1.67","volume":"95","author":"F Dazzi","year":"2000","unstructured":"Dazzi F, Szydlo RM, Craddock C et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood 2000; 95: 67\u201371.","journal-title":"Blood"},{"key":"BF1704381_CR24","first-page":"1997","volume":"100","author":"J Sierra","year":"2002","unstructured":"Sierra J, Perez WS, Rozman C et al. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood 2002; 100: 1997\u20132004.","journal-title":"Blood"},{"key":"BF1704381_CR25","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1182\/blood.V99.12.4370","volume":"99","author":"P Guardiola","year":"2002","unstructured":"Guardiola P, Runde V, Bacigalupo A et al. Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood 2002; 99: 4370\u20134378.","journal-title":"Blood"},{"key":"BF1704381_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.bmt.1703215","volume":"28","author":"N Kroger","year":"2001","unstructured":"Kroger N, Schetelig J, Zabelina T et al. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. Bone Marrow Transplant 2001; 28: 643\u2013647.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704381_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1046\/j.1365-2141.2002.03796.x","volume":"119","author":"JE Parker","year":"2002","unstructured":"Parker JE, Shafi T, Pagliuca A et al. Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens. Br J Haematol 2002; 119: 144\u2013154.","journal-title":"Br J Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704381","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:13:16Z","timestamp":1648077196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,12]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,3,1]]}},"alternative-id":["BF1704381"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704381","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2004,1,12]]},"assertion":[{"value":"31 March 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}